IDA Nacharam, Plot 28-29 Hyderabad, Telangana, 500076 IndiaSymbol Discovery Private Limited, a Contract Research Organization (CRO) supports and extends services to Pharmaceuticals and Biotech companies in their Drug Discovery efforts. Our organization offers a wide range of services designed to accelerate drug development process, reduces costs, and increase the likelihood of success. We provide chemistry- focused CRO services in drug discovery encompass a variety of essential activities, each contributing to the identification and optimization of potential drug candidates. Some key aspects of “Drug Discovery-Synthetic Chemistry” services offered by Symbol Discovery Pvt Ltd are; 1. Medical Chemistry – We have a team of experienced Ph.D. candidates with expertise in medicinal chemistry – specialized in designing and synthesizing novel compounds. 2. Custom Synthesis – Includes the synthesis of building blocks, intermediates, and reference standards. Our service enables efficient access to specialized compounds, crucial for exploring Structure-Activity Relationships (SAR). 3. Lead Identification – To identify Lead Compounds through Virtual Screening, High-Throughput Screening (HTS), and Fragment-Based Screening. Our techniques help identify initial hits that exhibit promising biological activity against the target of interest. 4. Lead Optimization – Our CRO play a vital role in optimizing their chemical structures – process involves iterative design and synthesis of analogs to enhance potency, selectivity, pharmacokinetics, and other drug-like properties. 5. Library Design – We extend services to design and maintain diverse compound libraries used for screening against specific targets. We also design custom libraries tailored to our client’s needs. 6. Structure Based Drugs Design (SBDD) – using Protein Crystallography, CryoEM. The collaborative nature of Symbol Discovery Pvt Ltd with its partners/ clients accelerates the identification of potential drug candidates, ultimately advancing the development of new therapies for various medical conditions.

TBI-UoH, School of Life Sciences, lab no 33 Telangana Hyderabad, Telangana, 500046 IndiaSymbol Discovery Private Limited, a Contract Research Organization (CRO) supports and extends services to Pharmaceuticals and Biotech companies in their Drug Discovery efforts. Our organization offers a wide range of services designed to accelerate drug development process, reduces costs, and increase the likelihood of success. We provide chemistry- focused CRO services in drug discovery encompass a variety of essential activities, each contributing to the identification and optimization of potential drug candidates. Some key aspects of “Drug Discovery-Synthetic Chemistry” services offered by Symbol Discovery Pvt Ltd are; 1. Medical Chemistry – We have a team of experienced Ph.D. candidates with expertise in medicinal chemistry – specialized in designing and synthesizing novel compounds. 2. Custom Synthesis – Includes the synthesis of building blocks, intermediates, and reference standards. Our service enables efficient access to specialized compounds, crucial for exploring Structure-Activity Relationships (SAR). 3. Lead Identification – To identify Lead Compounds through Virtual Screening, High-Throughput Screening (HTS), and Fragment-Based Screening. Our techniques help identify initial hits that exhibit promising biological activity against the target of interest. 4. Lead Optimization – Our CRO play a vital role in optimizing their chemical structures – process involves iterative design and synthesis of analogs to enhance potency, selectivity, pharmacokinetics, and other drug-like properties. 5. Library Design – We extend services to design and maintain diverse compound libraries used for screening against specific targets. We also design custom libraries tailored to our client’s needs. 6. Structure Based Drugs Design (SBDD) – using Protein Crystallography, CryoEM. The collaborative nature of Symbol Discovery Pvt Ltd with its partners/ clients accelerates the identification of potential drug candidates, ultimately advancing the development of new therapies for various medical conditions.